메뉴 건너뛰기




Volumn 52, Issue 5, 2011, Pages 617-620

Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and inflammatory bowel disease

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CAPECITABINE; FLUOROURACIL; GLUCOCORTICOID; INFLIXIMAB; IRIDIUM 192; LOPERAMIDE; MESALAZINE; METRONIDAZOLE; MOLECULAR MARKER;

EID: 79955550223     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181f9a5d2     Document Type: Article
Times cited : (12)

References (25)
  • 2
    • 0033965020 scopus 로고    scopus 로고
    • The lung in inflammatory bowel disease
    • DOI 10.1034/j.1399-3003.2000.15a03.x
    • Camus P, Colby TV. The lung in inflammatory bowel disease. Eur Respir J 2000;15:5-10. (Pubitemid 30068928)
    • (2000) European Respiratory Journal , vol.15 , Issue.1 , pp. 5-10
    • Camus, Ph.1    Colby, T.V.2
  • 5
    • 15744389434 scopus 로고    scopus 로고
    • Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
    • DOI 10.1053/j.gastro.2004.12.048
    • Shaib YH, El-Serag HB, Davila JA, et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005;128:620-6. (Pubitemid 40585364)
    • (2005) Gastroenterology , vol.128 , Issue.3 , pp. 620-626
    • Shaib, Y.H.1    El-Serag, H.B.2    Davila, J.A.3    Morgan, R.4    Mcglynn, K.A.5
  • 7
    • 53549129739 scopus 로고    scopus 로고
    • Cholangiocarcinoma presenting in an adolescent with vertically acquired HIV infection
    • Mangeya N, Mafukidze AT, Pascoe M, et al. Cholangiocarcinoma presenting in an adolescent with vertically acquired HIV infection. Int J STD AIDS 2008;19:717-8.
    • (2008) Int. J. STD AIDS , vol.19 , pp. 717-718
    • Mangeya, N.1    Mafukidze, A.T.2    Pascoe, M.3
  • 8
    • 0017744962 scopus 로고
    • Cholangiocarcinoma associated with biliary cirrhosis due to congenital biliary atresia
    • Kulkarni PB, Beatty E. Cholangiocarcinoma associated with biliary cirrhosis due to congenital biliary atresia. Am J Dis Child 1977;131: 442-4. (Pubitemid 8095768)
    • (1977) American Journal of Diseases of Children , vol.131 , Issue.4 , pp. 442-444
    • Kulkarni, P.B.1    Beatty Jr., E.C.2
  • 9
    • 0025142371 scopus 로고
    • Cholangiocarcinoma occurring after childhood radiotherapy for Wilm's tumor
    • Cunningham JJ. Cholangiocarcinoma occurring after childhood radiotherapy for Wilm's tumor. Hepatogastroenterology 1990;37:395-7. (Pubitemid 20298892)
    • (1990) Hepato-Gastroenterology , vol.37 , Issue.4 , pp. 395-397
    • Cunningham, J.J.1
  • 10
    • 0032815625 scopus 로고    scopus 로고
    • Choledochal cystic malignancies
    • Bismuth H, Krissat J. Choledochal cystic malignancies. Ann Oncol 1999;10(Suppl 4):94-8.
    • (1999) Ann. Oncol. , vol.10 , Issue.4 , pp. 94-98
    • Bismuth, H.1    Krissat, J.2
  • 13
    • 34547635802 scopus 로고    scopus 로고
    • Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis
    • DOI 10.1111/j.1572-0241.2007.01220.x
    • Björnsson E, Angulo P. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis. Am J Gastroenterol 2007; 102:1677-82. (Pubitemid 47206674)
    • (2007) American Journal of Gastroenterology , vol.102 , Issue.8 , pp. 1677-1682
    • Bjornsson, E.1    Angulo, P.2
  • 15
    • 33846085611 scopus 로고    scopus 로고
    • Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study
    • DOI 10.1111/j.1572-0241.2006.00872.x
    • Tischendorf JJ, Hecker H, Kruger M, et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 2007;102:107-14. (Pubitemid 46072050)
    • (2007) American Journal of Gastroenterology , vol.102 , Issue.1 , pp. 107-114
    • Tischendorf, J.J.W.1    Hecker, H.2    Kruger, M.3    Manns, M.P.4    Meier, P.N.5
  • 16
    • 0031914317 scopus 로고    scopus 로고
    • Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case-control study
    • DOI 10.1002/hep.510270201
    • Bergquist A, Glaumann H, Persson B, et al. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998;27:311-6. (Pubitemid 28081041)
    • (1998) Hepatology , vol.27 , Issue.2 , pp. 311-316
    • Bergquist, A.1    Glaumann, H.2    Persson, B.3    Broome, U.4
  • 17
    • 0033985615 scopus 로고    scopus 로고
    • Cholangiocarcinoma in primary sclerosing cholangitis: Who is at risk and how do we screen?
    • de Groen PC. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen? Hepatology 2000;31: 247-8 (Pubitemid 30033715)
    • (2000) Hepatology , vol.31 , Issue.1 , pp. 247-248
    • De Groen, P.C.1
  • 18
    • 0026086105 scopus 로고
    • Cholangiocarcinoma complicating primary sclerosing cholangitis
    • Rosen CB, Nagorney DM, Wiesner RH, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991;213:21-5.
    • (1991) Ann. Surg. , vol.213 , pp. 21-25
    • Rosen, C.B.1    Nagorney, D.M.2    Wiesner, R.H.3
  • 19
    • 54449084021 scopus 로고    scopus 로고
    • Utility of serum tumor markers imaging and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis
    • Charatcharoenwitthaya P, Enders FB, Halling KC, et al. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 2008;48: 1106-17.
    • (2008) Hepatology , vol.48 , pp. 1106-1117
    • Charatcharoenwitthaya, P.1    Enders, F.B.2    Halling, K.C.3
  • 20
    • 23944440978 scopus 로고    scopus 로고
    • The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis
    • DOI 10.1007/s10620-005-2927-8
    • Levy C, Lymp J, Angulo P, et al. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci 2005;50:1734-40. (Pubitemid 41203674)
    • (2005) Digestive Diseases and Sciences , vol.50 , Issue.9 , pp. 1734-1740
    • Levy, C.1    Lymp, J.2    Angulo, P.3    Gores, G.J.4    Larusso, N.5    Lindor, K.D.6
  • 21
    • 0342470390 scopus 로고    scopus 로고
    • CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis
    • Bjornsson E, Kilander A, Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 1999;19:501-8. (Pubitemid 30019064)
    • (1999) Liver , vol.19 , Issue.6 , pp. 501-508
    • Bjornsson, E.1    Kilander, A.2    Olsson, R.3
  • 22
    • 46049090963 scopus 로고    scopus 로고
    • Current diagnosis and management of primary sclerosing cholangitis
    • DOI 10.1002/lt.21456
    • Tischendorf JJ, Geier A, Trautwein C. Current diagnosis and management of primary sclerosing cholangitis. Liver Transpl 2008;14:735-46. (Pubitemid 351895502)
    • (2008) Liver Transplantation , vol.14 , Issue.6 , pp. 735-746
    • Tischendorf, J.J.W.1    Geier, A.2    Trautwein, C.3
  • 25
    • 33845941584 scopus 로고    scopus 로고
    • Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma
    • DOI 10.1097/01.tp.0000253551.43583.d1, PII 0000789020061227000034
    • Heimbach JK, Gores GJ, Haddock MG, et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006;82:1703-7. (Pubitemid 46035655)
    • (2006) Transplantation , vol.82 , Issue.12 , pp. 1703-1707
    • Heimbach, J.K.1    Gores, G.J.2    Haddock, M.G.3    Alberts, S.R.4    Pedersen, R.5    Kremers, W.6    Nyberg, S.L.7    Ishitani, M.B.8    Rosen, C.B.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.